Toy M - Search Results

1

Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.

Tordrup D, Hutin Y, Stenberg K, Lauer JA, Hutton DW, Toy M, Scott N, Bulterys M, Ball A, Hirnschall G. Tordrup D, et al. Among authors: toy m. Lancet Glob Health. 2019 Sep;7(9):e1180-e1188. doi: 10.1016/S2214-109X(19)30272-4. Epub 2019 Jul 25. Lancet Glob Health. 2019. PMID: 31353061 Free article.

2

Cost-effectiveness of viral hepatitis B & C treatment.

Toy M. Toy M. Best Pract Res Clin Gastroenterol. 2013 Dec;27(6):973-85. doi: 10.1016/j.bpg.2013.08.020. Epub 2013 Sep 27. Best Pract Res Clin Gastroenterol. 2013. PMID: 24182615 Review.

3

Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China.

Toy M, Hutton DW, So SK. Toy M, et al. PLoS One. 2015 Nov 4;10(11):e0139876. doi: 10.1371/journal.pone.0139876. eCollection 2015. PLoS One. 2015. PMID: 26536626 Free PMC article.

4

Population Health And Economic Impacts Of Reaching Chronic Hepatitis B Diagnosis And Treatment Targets In The US.

Toy M, Hutton DW, So S. Toy M, et al. Health Aff (Millwood). 2018 Jul;37(7):1033-1040. doi: 10.1377/hlthaff.2018.0035. Health Aff (Millwood). 2018. PMID: 29985701

5

The Hep B Calculator: an online tool for cost-effectiveness analyses of treatment.

Toy M, Hutton DW, Lauer J, Bulterys M, Hutin Y, So S. Toy M, et al. Lancet Gastroenterol Hepatol. 2019 Sep;4(9):668. doi: 10.1016/S2468-1253(19)30223-7. Epub 2019 Jul 27. Lancet Gastroenterol Hepatol. 2019. PMID: 31362918 No abstract available.

6

Hepatitis B cure: modeling the economics of a potential cost of a cure.

Toy M, So S, Hutton DW. Toy M, et al. Curr Opin HIV AIDS. 2020 May;15(3):208-212. doi: 10.1097/COH.0000000000000617. Curr Opin HIV AIDS. 2020. PMID: 32209813 Review.

7

Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income.

Tordrup D, Hutin Y, Stenberg K, Lauer JA, Hutton DW, Toy M, Scott N, Chhatwal J, Ball A. Tordrup D, et al. Among authors: toy m. Value Health. 2020 Dec;23(12):1552-1560. doi: 10.1016/j.jval.2020.06.015. Epub 2020 Oct 9. Value Health. 2020. PMID: 33248510 Free PMC article.

8

Cost-Effectiveness of 1-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States.

Toy M, Hutton D, Harris AM, Nelson N, Salomon JA, So S. Toy M, et al. Clin Infect Dis. 2022 Jan 29;74(2):210-217. doi: 10.1093/cid/ciab405. Clin Infect Dis. 2022. PMID: 33956937

9

The price tag of a potential cure for chronic hepatitis B infection: A cost threshold analysis for USA, China and Australia.

Toy M, Hutton D, McCulloch K, Romero N, Revill PA, Penicaud MC, So S, Cowie BC. Toy M, et al. Liver Int. 2022 Jan;42(1):16-25. doi: 10.1111/liv.15027. Epub 2021 Aug 8. Liver Int. 2022. PMID: 34328697

10

Letter to the editor: Importance of universal screening for chronic hepatitis B infection in adults in the United States.

Cohen C, Moraras K, Jackson M, Kamischke M, Gish RG, Brosgart CL, Toy M, Hutton D, Block TM, Wang S, So S. Cohen C, et al. Among authors: toy m. Hepatology. 2022 Apr;75(4):1062-1063. doi: 10.1002/hep.32304. Epub 2022 Jan 8. Hepatology. 2022. PMID: 34951931 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters